FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:930-936 March 30, 2000 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Patients infected with human immunodeficiency virus type 1 (HIV-1) are susceptible to neoplasms, including Kaposi's sarcoma, non-Hodgkin's lymphoma, and anal and cervical carcinoma.^1,2,3,4,5 Some of these neoplasms have been associated with oncogenic infectious agents such as human herpesvirus 8 (HHV-8), Epstein–Barr virus (EBV), human T-cell leukemia–lymphoma virus type I (also known as human T-cell lymphotropic virus type I; HTLV-I), and the human papillomavirus (HPV).^1,2,3,4,5 Presumably, the immunosuppression caused by HIV-1 allows for the expansion of virally transformed cells and the development of cancer.

HTLV-I and human T-cell lymphotropic virus type II (HTLV-II) are oncogenic retroviruses.^6,7 HTLV-I infects CD4+ T cells . . . [Full Text of this Article]

Case Report

Methods

Skin Biopsy

Peripheral Blood

Establishment and Characterization of a T-Cell Line Derived from the Peripheral Blood

Results

Discussion

Source Information

From the Departments of Medicine (B.P., D.D., S.D., J.L.) and Pathology (A.U., R.H.), State University of New York Upstate Medical University, Syracuse; and Cellular Products, Buffalo, N.Y. (L.P.).

Address reprint requests to Dr. Poiesz at the Department of Medicine, SUNY Health Science Center at Syracuse, 750 E. Adams St., Syracuse, NY 13210.

References

Related Letters:

HIV-1 and an HTLV-II–Associated Cutaneous T-Cell Lymphoma
Guitart J., Poiesz B. J., Dube D., Hutchison R.
Extract | Full Text  
N Engl J Med 2000; 343:303-304, Jul 27, 2000. Correspondence

This article has been cited by other articles:

• Wabulya, A., Imitola, J., Santagata, S., Kesari, S. (2007). Mycosis Fungoides With Leptomeningeal Involvement. JCO 25: 5658-5661 [Full Text]  
• Grogg, K L, Miller, R F, Dogan, A (2007). HIV infection and lymphoma. J. Clin. Pathol. 60: 1365-1372 [Abstract] [Full Text]  
• Xie, L., Yamamoto, B., Haoudi, A., Semmes, O. J., Green, P. L. (2006). PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo. Blood 107: 1980-1988 [Abstract] [Full Text]  
• Meertens, L., Chevalier, S., Weil, R., Gessain, A., Mahieux, R. (2004). A 10-Amino Acid Domain within Human T-cell Leukemia Virus Type 1 and Type 2 Tax Protein Sequences Is Responsible for Their Divergent Subcellular Distribution. J. Biol. Chem. 279: 43307-43320 [Abstract] [Full Text]  
• Kempf, W., Kadin, M. E., Dvorak, A. M., Lord, C. C., Burg, G., Letvin, N. L., Koralnik, I. J. (2003). Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin. Carcinogenesis 24: 301-306 [Full Text]  
• Bovolenta, C., Pilotti, E., Mauri, M., Panzeri, B., Sassi, M., Dall'Aglio, P., Bertazzoni, U., Poli, G., Casoli, C. (2002). Retroviral Interference on STAT Activation in Individuals Coinfected with Human T Cell Leukemia Virus Type 2 and HIV-1. J. Immunol. 169: 4443-4449 [Abstract] [Full Text]  
• Bovolenta, C., Pilotti, E., Mauri, M., Turci, M., Ciancianaini, P., Fisicaro, P., Bertazzoni, U., Poli, G., Casoli, C. (2002). Human T-cell leukemia virus type 2 induces survival and proliferation of CD34+ TF-1 cells through activation of STAT1 and STAT5 by secretion of interferon-gamma and granulocyte macrophage-colony-stimulating factor. Blood 99: 224-231 [Abstract] [Full Text]  
• Guitart, J., Poiesz, B. J., Dube, D., Hutchison, R. (2000). HIV-1 and an HTLV-II-Associated Cutaneous T-Cell Lymphoma. NEJM 343: 303-304 [Full Text]